XPH Looks Tempting, but the Five-Year Chart Warns Investors
SPDR S&P Pharmaceuticals ETF has delivered a standout one-year run, yet the longer five-year view casts a shadow. The...
This article explains When To Use Total Return Index Rather Than Price Index, outlining scenarios where total return offers clearer insight.
28,063 articlesSPDR S&P Pharmaceuticals ETF has delivered a standout one-year run, yet the longer five-year view casts a shadow. The...
Geopolitical shocks often rattle heavy machinery stocks like Caterpillar. This guide breaks down the buy, sell, or ho...
Chevron sits at the heart of today’s energy debate: steady production, looming supply gaps, and the question every in...
Berkshire Hathaway’s massive cash pile has long frustrated investors. Now the company is finally putting some of that...
As consumer debt climbs, a sharp cost comparison shows bankruptcy can wipe out unsecured balances in months, while lo...
A little-known international ETF is quietly outperforming the S&P 500 this year, riding a multi-factor strategy and l...
Income investing isn't one-size-fits-all. This hands-on comparison weighs AGNC's high-yield potential against Realty ...
Illinois has floated a plan to fix its long-broken alcohol tax system. This article explains what the proposal actual...
When a venerable logistics giant trades near the $120 mark, investors debate more than price. This guide weighs the u...
A space-focused Nasdaq-100 entrant is drawing attention after earnings and a key index promotion. Investors see a pot...
A new defense-focused ETF began trading in July 2026, joining VistaShares’ space and robotics funds as investors chas...
As mid-2026 market volatility persists, TQQQ’s apparent gains may fade behind hidden costs. This report breaks down t...